Business NewsPR NewsWire • Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®

HELSINKI, March 22, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has today launched the next generation of its STARMAP® AI (artificial intelligence) platform, v2.0. The technology utilizes sparse-data AI to augment experimental results...

View More : https://www.prnewswire.com:443/news-releases/nanoform-launches-next-generation-starmap-v2-0--the-ai-based-drug-candidate...
Releted News by prnewswire
15 Best Slots Online: The Top Slot Machine Sites in USA with High RTP, Real Money, and Free Spins
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Extended Stay America, Inc. - STAY
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of RumbleOn, Inc. - RMBL
Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®
TIAS Releases Final Report on Project to Support Formation of Sport Academy as Part of "Sport for Tomorrow" Program
Zalando Launches Spring Campaign to Laud Society's Champions & Celebrate Their Values